These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 4425844

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome.
    Bajpai A, Bagga A, Hari P, Dinda A, Srivastava RN.
    Pediatr Nephrol; 2003 Apr; 18(4):351-6. PubMed ID: 12700961
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome.
    McCrory WW, Shibuya M, Lu WH, Lewy JE.
    J Pediatr; 1973 Apr; 82(4):614-8. PubMed ID: 4698338
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children.
    Lancet; 1974 Aug 24; 2(7878):423-7. PubMed ID: 4137139
    [No Abstract] [Full Text] [Related]

  • 12. Cyclophosphamide in the treatment of idiopathic nephrotic syndrome.
    Pennisi AJ, Grushkin CM, Lieberman E.
    Pediatrics; 1976 Jun 24; 57(6):948-51. PubMed ID: 934751
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
    Kyrieleis HA, Levtchenko EN, Wetzels JF.
    Am J Kidney Dis; 2007 May 24; 49(5):592-7. PubMed ID: 17472840
    [Abstract] [Full Text] [Related]

  • 14. Cyclophosphamide therapy in adults with minimal-change nephrotic syndrome.
    Uldall PR, Feest TG, Morley AR, Tomlinson BE, Kerr DN.
    Lancet; 1972 Jun 10; 1(7763):1250-3. PubMed ID: 4113514
    [No Abstract] [Full Text] [Related]

  • 15. Long-term assessment of cyclophosphamide therapy for nephrosis in children.
    McDonald J, Murphy AV, Arneil GC.
    Lancet; 1974 Oct 26; 2(7887):980-2. PubMed ID: 4138088
    [No Abstract] [Full Text] [Related]

  • 16. Cyclophosphamide therapy in the nephrotic syndrome in childhood.
    Moncrieff MW, White RH, Oggs CS, Cameron JS.
    Br Med J; 1969 Mar 15; 1(5645):666-71. PubMed ID: 5774315
    [Abstract] [Full Text] [Related]

  • 17. A controlled trial of cyclophosphamide and azathioprine in Nigerian children with the nephrotic syndrome and poorly selective proteinuria.
    Adeniyi A, Hendrickse RG, Soothill JF.
    Arch Dis Child; 1979 Mar 15; 54(3):204-7. PubMed ID: 373645
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Differential protein clearances and response to treatment in Nigerian nephrotic children.
    Adeniyi A, Hendrickse RG, Soothill JF.
    Arch Dis Child; 1976 Sep 15; 51(9):691-6. PubMed ID: 793539
    [Abstract] [Full Text] [Related]

  • 20. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
    Gulati A, Sinha A, Gupta A, Kanitkar M, Sreenivas V, Sharma J, Mantan M, Agarwal I, Dinda AK, Hari P, Bagga A.
    Kidney Int; 2012 Nov 15; 82(10):1130-5. PubMed ID: 22763815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.